Skip to main content
Signal8

VOLITIONRX LTD (VNRX)

Sector: In Vitro & In Vivo Diagnostic Substances

Industry: Medical - Devices

VolitionRX Ltd logo

VolitionRX Ltd

NYSE:VNRXHealthcare
-5.56%$0.1887
CLOSED
AH$0.1801-4.56%vs close
Mkt Cap$6.81M
EV-
Float35.56M
O/S36.08M
VOL3.08M sh
$ Vol$597K
RVOL0.81×
Inst Own7.5%
SI3.9%
Net Cash/Sh-
Dilution
VolitionRX Ltd logoNYSE:VNRXClosed$0.1887-5.56%
Historical Data
DateOpenHighLowCloseVolume
Nov 17, 20260.20300.20300.18050.18873,098,475
Nov 16, 20260.22900.22900.19020.19984,645,917
Nov 13, 20260.19970.24200.19350.230056,935,764
Nov 12, 20260.20000.20900.18250.1845995,894
Nov 11, 20260.19330.20360.18800.2036681,852
Nov 10, 20260.20500.21000.17820.1844757,965
Nov 9, 20260.19590.20490.19390.2000401,469
Nov 6, 20260.19020.20000.18850.1959468,083
Nov 5, 20260.20770.20990.18320.1890563,004
Nov 4, 20260.19480.20400.19480.2031397,971
Nov 3, 20260.21120.21390.18650.1930850,519
Nov 2, 20260.20010.22000.19500.21011,264,289
Oct 30, 20260.20000.20030.18300.19531,063,275
Oct 29, 20260.18430.20000.17300.19751,093,345
Oct 28, 20260.19000.19240.17070.18181,245,301
Oct 27, 20260.19000.19270.16010.18503,975,656
Oct 26, 20260.17500.18040.17390.1786610,916
Oct 23, 20260.16520.17830.16520.1741509,191
Oct 22, 20260.16520.17100.15640.16911,677,045
Oct 21, 20260.17000.17260.16420.1664494,725
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
5
HOLD
3
SELL
0
TOTAL8
Insider Trades
InsiderTypeShares
Batchelor Ann-Louise profile photoBatchelor Ann-LouiseGrant/Award12.0K
Forterre Gael profile photoForterre GaelAutomatic Sell5.3K
Rootsaert Rodney Gerard profile photoRootsaert Rodney GerardAutomatic Sell3.9K
Micallef Jacob Vincent profile photoMicallef Jacob VincentAutomatic Sell5.3K
Plummer Nicholas profile photoPlummer NicholasAutomatic Sell7.0K
Rootsaert Rodney Gerard profile photoRootsaert Rodney GerardAutomatic Sell3.3K
Shareholders
7.5%
Institutional
(28)
1.1%
Insiderⓘ
(17)
1.3%
5%+ Owners
(2)
of which 0.4% rests on schedules older than 24 months (1 holder)
90.1%
Unattributed (incl. retail)ⓘ
Institutional7.5%
Insider1.1%
5%+ Beneficial1.3%
Unattributed (incl. retail)90.1%
Sources: 13F, Form 4, 13D/13GO/S: 36.1M · as of 5 Nov 2026 · SEC filings
Insiders & Institutional Holders
About

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia.

The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.

It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.

Key Metrics
Market Cap$6.81M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership7.50%

based on 36.08M shares outstanding

SectorHealthcare
IndustryMedical - Devices
ExchangeNYSE American
CountryUSUS
IPO DateMar 2, 2012
Shares Outstanding36.08M
Authorized Shares
Float35.56M
SEC Float (non-affiliate)35.58M
52-Week Range
$0.1564$7.73
$0.1887(0th percentile)
Volume
Average Daily Volume3.80M
3.10M today vs 3.80M avg(-18%)

30d Avg

3.80M

60d Avg

2.81M

90d Avg

9.68M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Signal8's dilution snapshot of VNRX as of Sep 30, 2026 records an effective S-3 shelf registration (effective Sep 9, 2026), an at-the-market sales agreement dated Apr 22, 2025, 19 outstanding warrant series and a registered direct offering closed Jun 9, 2026, from SEC filings. VolitionRX Ltd (NYSE: VNRX) traded at $0.1887 on Nov 17, 2026, down 5.56% from the previous close of $0.1998. 52-week range: $0.1564 to $7.73. The company is in the Healthcare sector (Medical - Devices).